From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Golden Prospect Precious Metals – interims, a gold momentum Buy

By HotStockRockets | Friday 6 September 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Precious metals sector companies investment trust Golden Prospect Precious Metals (GPM) has announced results for the first half of 2024, noting a 15.64% Net Asset Value total return per share to 41.42p and outperformance of the gold price (+c.13% in USD and GBP) and of the gold miners’ Exchange Traded Funds (+10.1% and +10.8% in GBP) – and that “having endured three years where gold miners lagged the gold price, this may be the first tentative step in returning to their traditional role, of outperforming precious metals prices on the upside”. There is therefore very strong near term upside potential from a 38p offer price for these shares.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 11:47:12